Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.
Aphea.Bio has raised €84M across 2 funding rounds from 6 investors, most recently a Series C round in Jul 2023. Based in Zwijnaarde, Belgium; founded 2017; active in Agritech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2023-07-12 | Series C | €70M | Astanor Ventures,Bill & Melinda Gates Foundation Trust ,BNP Paribas Fortis,European Circular Bioeconomy Fund (ECBF),Innovation Industries,Korys Investments | View deal → |
| 2020-11-30 | Series B | €14M | Astanor Ventures | View deal → |
